Class III antiarrhythmic

0 marketed 1 in Phase 3

This page covers all Class III antiarrhythmic drugs tracked by Drug Landscape: marketed products and active clinical-stage compounds, targeting Sodium channels.

Targets

Sodium channels

Phase 3 pipeline (1)